A decreasing trend in body mass index (BMI) percentile during the course of the study was observed, with weight decrease reported as an adverse event in 13 participants [ 19 ].
← all excerpts
A historical overview of the cardiovascular safety of sodium oxybate: clinical trials, clinical experience.
1
—
—